Search clinical trials for: ACTIVA BioACTIVE-RESTORATIVE

Total 10000 results

Massachusetts General Hospital
National Comprehensive Cancer Network

Unknown

Adjuvant Afatinib in Stage I-III NSCLC With EGFR Mutation

Non Small Cell Lung Cancer

United States
Memorial Sloan Kettering Cancer Center
Novartis; National Comprehensive Cancer Network

Completed

Adjuvant Dabrafenib (GSK2118436) in Patients With Surgically Resected AJCC Stage IIIC Melanoma Characterized by a BRAFV600E/K Mutation

Melanoma

United States
Sucampo Pharma Americas, LLC
Sucampo AG

Completed

Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional Constipation

Constipation - Functional

United States
Bayer

Completed

Study on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given as a Single Oral Dose of 1 mg Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and Weight

Clinical Pharmacology

Germany
Boehringer Ingelheim

Completed

GIOTRIF in First Line Therapy of Advanced NSCLC With EGFR-mutations

Carcinoma, Non-Small-Cell Lung

Germany
Yabao Pharmaceutical Group

Completed

Multiple Ascending Doses of Globalagliatin Hydrochloride in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus | Hyperglycaemia (Diabetic)

China
Samsung Medical Center

Withdrawn

Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric Cancer

Gastric Cancer

Korea, Republic of
Assiut University

Unknown

Some Biomarkers in Bronchial Asthma in Children

Bronchial Asthma
University of Medicine and Pharmacy at Ho Chi Minh...

Unknown

Efficacy of Intravenous Tissue-type Plasminogen Activator on Acute Ischemic Stroke Patients With Large Vessel Occlusions

Stroke, Ischemic | Stroke, Acute

Vietnam
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Unknown

Effect and Safety of Apatinib on Radiation-Induced Brain Injury

Radiation Injuries

China
Second Affiliated Hospital, School of Medicine,...

Unknown

A Trial to Evaluate the Combination Efficacy of Artificial Dermis and Growth Factor in Chronic Wounds Ulcer

Chronic Wound
Groupe Hospitalier Pitie-Salpetriere
Institut National de la Santé Et de la Recherche Médicale, France

Completed

Immune CHeckpoint Inhibitors Monitoring of Adverse Drug ReAction (CHIMeRA)

Autoimmune Diseases | Endocrine System Diseases | Cancer | Arthritis | Myositis | Neuropathy | Cardiac Disease | Ophthalmopathy

France
University of Texas Southwestern Medical Center
Novartis

Withdrawn

Ceritinib in Mutation and Oncogene Directed Therapy in Thyroid Cancer

Metastatic Anaplastic Thyroid Cancer | Locally Advanced Anaplastic, Undifferentiated Thyroid Cancer

United States
Maastricht University Medical Center

Unknown

18F-Flutemetamol and Plaque Vulnerability

Atherosclerosis

Netherlands
Norman B. Gaylis, MD

Completed

An Evaluation of the Optimal Dose of Tofacitinib Needed to Achieve Low Disease Activity (LDA) or Clinical Remission in Patients With Active Rheumatoid Arthritis (RA) as Measured From a Clinical and Structural Perspective

Rheumatoid Arthritis

United States
Elpen Pharmaceutical Co. Inc.

Completed

Bosentan Treatment of Digital Ulcers Related to Systemic Sclerosis (GRegistry SCDU)

Scleroderma | Digital Ulcer | Systematic Sclerosis

Greece
University Health Network, Toronto

Completed

A Study of Radiation With Sorafenib in Advanced Cancer

Cancer

Canada
Hangzhou ACEA Pharmaceutical Research Co., Ltd.

Completed

Preliminary Evaluation of Safety and Efficacy by [14C] AC0010 Trail and Subsequent AC0010 Treatment

Carcinoma，Non-Small-Cell Lung

China
University Medical Center Groningen
Actelion

Completed

The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis (CEASESTIFF)

Scleroderma, Systemic

Netherlands
Boehringer Ingelheim

Approved for marketing

Expanded Access Study of Afatinib in Treatment-naive or Chemotherapy Pre-treated Patients With Non-small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

Korea, Republic of
Xuzhou Central Hospital

Unknown

Apatinib for Advanced Lung Squmamous Carcinoma

Lung Squamous Cell Carcinoma
Coney Island Hospital, Brooklyn, NY

Unknown

Cardiorenal Risk Stratification Pilot Study (CRiSPS)

Heart Failure | Chronic Kidney Diseases | Cardio-Renal Syndrome

United States
Dartmouth-Hitchcock Medical Center
Merck Sharp & Dohme LLC

Completed

A Clinical Trial to Validate Molecular Targets of Vorinostat in Patients With Aerodigestive Tract Cancer

Head and Neck Cancer | Esophageal Cancer | Lung Cancer | Aerodigestive Tract Cancer

United States
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

Hemodialysis | Hyperphosphatemia

Japan
Agios Pharmaceuticals, Inc.

Approved for marketing

Ivosidenib Expanded Access Program in Relapsed/Refractory AML With an IDH1 Mutation

Acute Myeloid Leukemia | Relapsed Pediatric AML | Relapsed Adult AML
Athenex, Inc.

Completed

Ph 1, Single-Center, Safety, Tolerability & Pharmacokinetic Study of KX2 391 Ointment in Subj. w Actinic Keratosis

Actinic Keratosis

United States
Bristol-Myers Squibb

Completed

A Study to Evaluate the Bioavailability of BMS-986205

Healthy Participants

United Kingdom
Tel-Aviv Sourasky Medical Center

Unknown

Brinzolamide for the Treatment of Chronic Central Serous Chorioretinopathy

Central Serous Chorioretinopathy

Israel, Argentina
Milton S. Hershey Medical Center
Genzyme, a Sanofi Company

Completed

Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney Disease

Chronic Kidney Disease

United States
Institut Paoli-Calmettes
CHU de Reims

Unknown

Autoimmune Cytopenia and BcR Inhibitors (CABRI)

Autoimmune Cytopenia Associated With Chronic Lymphocytic Leukemia

France
Cancer Research UK

Terminated

A Phase I Study of AZD0424 Alone and in Combination in Advanced Solid Tumours (AZD0424)

Advanced Solid Tumours

United Kingdom
Roxane Laboratories

Completed

Bioequivalency Study of Terbinafine Tablets Under Fasting Conditions

Onychomycosis

United States
Hebei Medical University Fourth Hospital

Unknown

Prospective, Multicenter, Observational Study of Apatinib Single or Combined Capecitabine for Treatment of Patients With Metastatic Her-2 Negative Breast Cancer

Breast Cancer Metastatic

China
Emory University

Completed

Enoxaparin Dosing in Obesity

Obesity

United States
Massachusetts General Hospital
Bristol-Myers Squibb; Dana-Farber Cancer Institute; Brigham and Women's Hospital

Completed

Dasatinib in Relapsed Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

United States
Anhui Provincial Hospital

Unknown

Research On the Optimized Treatment Method For Apatinib's Cure Of Advanced Gastric Cancer

Two Different Treatment Methods

China
Bayer

Completed

Measuring Outcomes In Patients With Pulmonary Arterial Hypertension Not on Active Treatment (MOTION)

Hypertension, Pulmonary

United States, Puerto Rico
Janssen Research & Development, LLC

No longer available

A Study to Provide Access to Trabectedin in Participants With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Persistent or Recurrent Disease and Who Are Not Expected to Benefit From Currently Available Standard of Care Treatment

Sarcoma

United States, Canada, Israel
Boehringer Ingelheim

Terminated

Afatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3)

Carcinoma, Non-Small-Cell Lung | ErbB Receptors

United States
Groupe Hospitalier Paris Saint Joseph

Withdrawn

Phase II Study of Afatinib as Third- or Further-line Treatment for Patients With Stage IV Bronchial Adenocarcinoma, Harboring Wild-type EGFR, Expressing the Neurotensin - Neurotensin Receptor Complex (THEN)

SMALL CELL LUNG CARCINOMA

France
Jean M. Tersak, M.D.
Pfizer

No longer available

Treatment With Crizotinib Single Patient Expanded Access IND 134375

Inflammatory Myofibroblastic Tumour
Shanghai Zhongshan Hospital

Unknown

Adjuvant Therapy With Apatinib for HCC Patients With PVTT Who Underwent Radical Resection

Carcinoma, Hepatocellular

China
Vanderbilt-Ingram Cancer Center

Terminated

PET/CT Evaluation of Treatment Response in Breast Cancer

Breast Cancer

United States
Pfizer

Terminated

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Psoriasis

United States, Spain, Korea, Republic of, Taiwan, Canada, Poland, Belgium, Denmark, Germany, Serbia, United Kingdom, France, Czechia, Hungary, Mexico, Colombia, Russian Federation, Croatia, Singapore, Australia, Austria, Slovakia, S... and more
Hospices Civils de Lyon

Completed

Direct-acting Antivirals and Hepatocellular Carcinoma Recurrence (RECAR)

Hepatocellular Carcinoma | Hepatitis C | Direct Acting Antivirals
OncoTherapy Science, Inc.

Completed

Phase 1 Study of OTS167 in Patients With Solid Tumors

Solid Tumors | Metastatic Tumors

United States
Junling Li

Unknown

The Efficacy and Safety of Apatinib Monotherapy in Maintenance Treatment of Extensive-stage Small-cell Lung Cancer

Apatinib in Maintenance Treatment

China
Yale University

Completed

Tofacitnib for the Treatment of Alopecia Areata and Variants

Alopecia Areata (AA) | Alopecia Totalis (AT) | Alopecia Universalis (AU)

United States
Hoffmann-La Roche

Completed

An Observational Study of First-Line Capecitabine Based Chemotherapy in Participants With Metastatic Colorectal Cancer (AXEL)

Colorectal Cancer

Hungary
Pfizer

Completed

Use Of Fragmin In Hemodialysis

Chronic Renal Failure

Canada

Search clinical trials for: ACTIVA BioACTIVE-RESTORATIVE

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations